Harmony Biosciences Holdings, Inc. SEC filings HRMY
Harmony Biosciences Holdings, Inc. has 460 filings in SEC EDGAR's recent list, going back to Feb 14, 2020. Its latest annual report, Form ARS, was filed on Apr 3, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 4, 2026 | Nov 4, 2026 |
| 8-K/A |
Amended current report
Officer or director change
|
Oct 30, 2026 | Oct 12, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 27, 2026 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Oct 13, 2026 | Oct 12, 2026 |
| 4 | Insider transaction | Sep 18, 2026 | Sep 16, 2026 |
| 144 | Notice of proposed sale | Sep 18, 2026 | — |
| 144 | Notice of proposed sale | Sep 17, 2026 | — |
| 144 | Notice of proposed sale | Sep 16, 2026 | — |
| 4 | Insider transaction | Sep 9, 2026 | Sep 4, 2026 |
| 144 | Notice of proposed sale | Sep 8, 2026 | — |
| 144 | Notice of proposed sale | Sep 4, 2026 | — |
| 144 | Notice of proposed sale | Aug 7, 2026 | — |
| 10-Q | Quarterly report | Aug 4, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 4, 2026 | Aug 4, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 31, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 28, 2026 | — |
| 3 | Initial insider ownership | Jul 22, 2026 | Jul 16, 2026 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Jul 16, 2026 | Jul 16, 2026 |
| 144 | Notice of proposed sale | Jul 2, 2026 | — |
| 144 | Notice of proposed sale | Jun 30, 2026 | — |
| 144 | Notice of proposed sale | Jun 26, 2026 | — |
| 144 | Notice of proposed sale | Jun 24, 2026 | — |
| 144 | Notice of proposed sale | Jun 9, 2026 | — |
| 144 | Notice of proposed sale | Jun 5, 2026 | — |
| 144 | Notice of proposed sale | Jun 4, 2026 | — |
| 4 | Insider transaction | May 18, 2026 | May 14, 2026 |
| 3 | Initial insider ownership | May 18, 2026 | May 14, 2026 |
| 4 | Insider transaction | May 18, 2026 | May 14, 2026 |
| 4 | Insider transaction | May 18, 2026 | May 14, 2026 |
| 4 | Insider transaction | May 18, 2026 | May 14, 2026 |
| 4 | Insider transaction | May 18, 2026 | May 14, 2026 |
| 4 | Insider transaction | May 18, 2026 | May 14, 2026 |
| 4 | Insider transaction | May 18, 2026 | May 1, 2026 |
| 4 | Insider transaction | May 18, 2026 | Apr 14, 2026 |
| 3 | Initial insider ownership | May 18, 2026 | Apr 14, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 14, 2026 | May 14, 2026 |
| 144 | Notice of proposed sale | May 8, 2026 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 7, 2026 | May 7, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 14, 2026 | Apr 14, 2026 |
| 4 | Insider transaction | Apr 9, 2026 | Apr 7, 2026 |
| 4 | Insider transaction | Apr 6, 2026 | Apr 2, 2026 |
| 4 | Insider transaction | Apr 6, 2026 | Apr 2, 2026 |
| 3 | Initial insider ownership | Apr 6, 2026 | Apr 2, 2026 |
| ARS | Annual report to shareholders | Apr 3, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 3, 2026 | — |
| DEF 14A | Proxy statement | Apr 3, 2026 | May 14, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 2, 2026 | Mar 31, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 27, 2026 | — |
| 10-K | Annual report | Feb 24, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 24, 2026 | Feb 24, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 5, 2026 | — |
| 4 | Insider transaction | Jan 28, 2026 | Jan 26, 2026 |
| 4 | Insider transaction | Jan 26, 2026 | Jan 22, 2026 |
| 4 | Insider transaction | Jan 26, 2026 | Jan 22, 2026 |
| 4 | Insider transaction | Jan 26, 2026 | Jan 22, 2026 |
| 4 | Insider transaction | Jan 26, 2026 | Jan 22, 2026 |
| 4 | Insider transaction | Jan 26, 2026 | Jan 22, 2026 |
| 144 | Notice of proposed sale | Jan 26, 2026 | — |
| 4 | Insider transaction | Jan 20, 2026 | Jan 15, 2026 |
| 144 | Notice of proposed sale | Jan 15, 2026 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 12, 2026 | Jan 12, 2026 |
| 4 | Insider transaction | Dec 17, 2025 | Dec 12, 2025 |
| 144 | Notice of proposed sale | Dec 12, 2025 | — |
| 4 | Insider transaction | Dec 9, 2025 | Dec 5, 2025 |
| 144 | Notice of proposed sale | Dec 5, 2025 | — |
| 4 | Insider transaction | Nov 25, 2025 | Nov 21, 2025 |
| 144 | Notice of proposed sale | Nov 21, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 5, 2025 | — |
| 10-Q | Quarterly report | Nov 4, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 4, 2025 | Nov 4, 2025 |
| 8-K |
Current report
Results of operations
|
Oct 23, 2025 | Oct 23, 2025 |
| 4 | Insider transaction | Oct 2, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 24, 2025 | Sep 24, 2025 |
| 4 | Insider transaction | Sep 2, 2025 | Aug 28, 2025 |
| 4 | Insider transaction | Aug 19, 2025 | Aug 15, 2025 |
| 144 | Notice of proposed sale | Aug 15, 2025 | — |
| 10-Q | Quarterly report | Aug 5, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 5, 2025 | Aug 5, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 11, 2025 | Jun 11, 2025 |
| 144 | Notice of proposed sale | Jun 10, 2025 | — |
| 8-K |
Current report
Other events
|
Jun 5, 2025 | Jun 5, 2025 |
| 144 | Notice of proposed sale | May 19, 2025 | — |
| 144 | Notice of proposed sale | May 16, 2025 | — |
| 4 | Insider transaction | May 16, 2025 | May 15, 2025 |
| 4 | Insider transaction | May 16, 2025 | May 15, 2025 |
| 4 | Insider transaction | May 16, 2025 | May 15, 2025 |
| 4 | Insider transaction | May 16, 2025 | May 15, 2025 |
| 4 | Insider transaction | May 16, 2025 | May 15, 2025 |
| 4 | Insider transaction | May 16, 2025 | May 15, 2025 |
| 4 | Insider transaction | May 16, 2025 | May 15, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 15, 2025 | May 15, 2025 |
| 144 | Notice of proposed sale | May 12, 2025 | — |
| 4 | Insider transaction | May 9, 2025 | May 1, 2025 |
| 144 | Notice of proposed sale | May 9, 2025 | — |
| 144 | Notice of proposed sale | May 8, 2025 | — |
| 144 | Notice of proposed sale | May 7, 2025 | — |
| 10-Q | Quarterly report | May 6, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 6, 2025 | May 6, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 29, 2025 | — |
| 4 | Insider transaction | Apr 16, 2025 | Apr 7, 2025 |
| 3 | Initial insider ownership | Apr 16, 2025 | Apr 7, 2025 |
| UPLOAD | Letter from the SEC | Apr 15, 2025 | — |
| CORRESP | Letter to the SEC | Apr 9, 2025 | — |
| 4 | Insider transaction | Apr 4, 2025 | Apr 2, 2025 |
| 3 | Initial insider ownership | Apr 4, 2025 | Apr 2, 2025 |
| ARS | Annual report to shareholders | Apr 4, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 4, 2025 | — |
| DEF 14A | Proxy statement | Apr 4, 2025 | May 15, 2025 |
| 4 | Insider transaction | Apr 3, 2025 | Apr 1, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 3, 2025 | Apr 2, 2025 |
| 144 | Notice of proposed sale | Apr 1, 2025 | — |
| 4 | Insider transaction | Apr 1, 2025 | Mar 29, 2025 |
| UPLOAD | Letter from the SEC | Mar 28, 2025 | — |
| 8-K |
Current report
Officer or director change, Other events
|
Mar 24, 2025 | Mar 20, 2025 |
| 4 | Insider transaction | Mar 5, 2025 | Mar 3, 2025 |
| 144 | Notice of proposed sale | Mar 3, 2025 | — |
| S-8 | Employee stock plan registration | Feb 25, 2025 | — |
| S-3ASR | Automatic shelf registration | Feb 25, 2025 | — |
| 10-K | Annual report | Feb 25, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 25, 2025 | Feb 25, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 12, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 10, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 5, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 30, 2025 | — |
| 4 | Insider transaction | Jan 28, 2025 | Jan 24, 2025 |
| 4 | Insider transaction | Jan 28, 2025 | Jan 24, 2025 |
| 4 | Insider transaction | Jan 28, 2025 | Jan 24, 2025 |
| 4 | Insider transaction | Jan 28, 2025 | Jan 24, 2025 |
| 4 | Insider transaction | Jan 28, 2025 | Jan 24, 2025 |
| 144 | Notice of proposed sale | Jan 27, 2025 | — |
| 144 | Notice of proposed sale | Jan 27, 2025 | — |
| 144 | Notice of proposed sale | Jan 24, 2025 | — |
| 4 | Insider transaction | Jan 23, 2025 | Jan 21, 2025 |
| 4 | Insider transaction | Jan 23, 2025 | Jan 21, 2025 |
| 4 | Insider transaction | Jan 21, 2025 | Jan 16, 2025 |
| 144 | Notice of proposed sale | Jan 21, 2025 | — |
| 144 | Notice of proposed sale | Jan 21, 2025 | — |
| 144 | Notice of proposed sale | Jan 21, 2025 | — |
| 4 | Insider transaction | Jan 16, 2025 | Jan 15, 2025 |
| 4 | Insider transaction | Jan 15, 2025 | Jan 13, 2025 |
| 144 | Notice of proposed sale | Jan 13, 2025 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 4 | Insider transaction | Nov 5, 2024 | Nov 1, 2024 |
| 4 | Insider transaction | Nov 5, 2024 | Nov 1, 2024 |
| 8-K |
Current report
Other events
|
Nov 1, 2024 | Oct 30, 2024 |
| 4 | Insider transaction | Oct 31, 2024 | Oct 29, 2024 |
| 424B7 | Filing | Oct 31, 2024 | — |
| 424B7 | Filing | Oct 29, 2024 | — |
| 144 | Notice of proposed sale | Oct 29, 2024 | — |
| 10-Q | Quarterly report | Oct 29, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Oct 29, 2024 | Oct 29, 2024 |
| 4 | Insider transaction | Oct 7, 2024 | Oct 3, 2024 |
| 144 | Notice of proposed sale | Oct 3, 2024 | — |
| 4 | Insider transaction | Oct 2, 2024 | Oct 1, 2024 |
| 4 | Insider transaction | Oct 2, 2024 | Sep 30, 2024 |
| 4 | Insider transaction | Oct 2, 2024 | Sep 30, 2024 |
| 144 | Notice of proposed sale | Oct 1, 2024 | — |
| 4 | Insider transaction | Oct 1, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 1, 2024 | Oct 1, 2024 |
| 144 | Notice of proposed sale | Sep 30, 2024 | — |
| 4 | Insider transaction | Sep 30, 2024 | Sep 27, 2024 |
| 144 | Notice of proposed sale | Sep 27, 2024 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 6, 2024 | Aug 6, 2024 |
| 10-Q | Quarterly report | Aug 6, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Officer or director change, Other events
|
Jul 1, 2024 | Jun 27, 2024 |
| 4 | Insider transaction | May 31, 2024 | May 29, 2024 |
| 4 | Insider transaction | May 31, 2024 | May 29, 2024 |
| 4 | Insider transaction | May 31, 2024 | May 29, 2024 |
| 4 | Insider transaction | May 31, 2024 | May 29, 2024 |
| 4 | Insider transaction | May 31, 2024 | May 29, 2024 |
| 4 | Insider transaction | May 31, 2024 | May 29, 2024 |
| 4 | Insider transaction | May 31, 2024 | May 29, 2024 |
| 8-K |
Current report
Shareholder vote results
|
May 29, 2024 | May 29, 2024 |
| 4 | Insider transaction | May 3, 2024 | May 1, 2024 |
| 8-K |
Current report
Officer or director change
|
May 3, 2024 | May 1, 2024 |
| 10-Q | Quarterly report | Apr 30, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Apr 30, 2024 | Apr 30, 2024 |
| ARS | Annual report to shareholders | Apr 11, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Material agreement, Other events
|
Apr 11, 2024 | Apr 6, 2024 |
| DEFA14A | Additional proxy material | Apr 11, 2024 | — |
| DEF 14A | Proxy statement | Apr 11, 2024 | May 29, 2024 |
| 4 | Insider transaction | Apr 2, 2024 | Mar 29, 2024 |
| 4 | Insider transaction | Mar 18, 2024 | Mar 15, 2024 |
| 144 | Notice of proposed sale | Mar 15, 2024 | — |
| 4 | Insider transaction | Mar 11, 2024 | Mar 8, 2024 |
| 144 | Notice of proposed sale | Mar 8, 2024 | — |
| 10-K/A | Amended annual report | Feb 28, 2024 | Dec 31, 2023 |
| S-8 | Employee stock plan registration | Feb 22, 2024 | — |
| 10-K | Annual report | Feb 22, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 22, 2024 | Feb 22, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 9, 2024 | — |
| 4 | Insider transaction | Jan 26, 2024 | Jan 24, 2024 |
| 3 | Initial insider ownership | Jan 26, 2024 | May 1, 2023 |
| 4 | Insider transaction | Jan 26, 2024 | Jan 24, 2024 |
| 4 | Insider transaction | Jan 26, 2024 | Jan 24, 2024 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- HRMY (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Plymouth Meeting, PA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1802665
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.